Dapagliflozin-d5

• CAT Number: S000042
• CAS Number: 1204219-80-6
• Molecular Formula: C21H20D5ClO6
• Molecular Weight: 413.9
• Purity: ≥95%
• Target: SGLT
• IUPAC Name: (2S,3R,4R,5S,6R)-2-[4-chloro-3-[[4-(1,1,2,2,2-pentadeuterioethoxy)phenyl]methyl]phenyl]-6-(hydroxymethyl)oxane-3,4,5-triol
• InChI: InChI=1S/C21H25ClO6/c1-2-27-15-6-3-12(4-7-15)9-14-10-13(5-8-16(14)22)21-20(26)19(25)18(24)17(11-23)28-21/h3-8,10,17-21,23-26H,2,9,11H2,1H3/t17-,18-,19+,20-,21+/m1/s1/i1D3,2D2
• InChIKey: JVHXJTBJCFBINQ-CAXKFZQOSA-N
• SMILES: [2H]C([2H])([2H])C([2H])([2H])OC1=CC=C(C=C1)CC2=C(C=CC(=C2)[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)Cl

Dapagliflozin-d5 is a high-purity deuterated compound used in advanced pharmaceutical research. This isotopically labeled version of Dapagliflozin is essential for studies involving SGLT2 inhibitors, diabetes therapeutics, pharmacokinetics, and metabolic pathways. Featuring five deuterium atoms, it ensures precise and reliable analytical results. Its advanced formulation provides enhanced stability and consistency, making it suitable for various experimental setups. Ideal for endocrinology research and drug development, Dapagliflozin-d5 integrates seamlessly into existing protocols, offering a robust and cost-effective solution for high-precision scientific investigations.